Compare BIOX & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIOX | BNGO |
|---|---|---|
| Founded | 2001 | 2003 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Agricultural Chemicals | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3M | 12.5M |
| IPO Year | 2019 | 2018 |
| Metric | BIOX | BNGO |
|---|---|---|
| Price | $0.23 | $1.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | ★ 218.1K | 171.3K |
| Earning Date | 11-16-2026 | 11-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,000,735.00 |
| Revenue This Year | $59.25 | $13.91 |
| Revenue Next Year | $34.94 | $33.34 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.19 | $1.00 |
| 52 Week High | $2.03 | $2.23 |
| Indicator | BIOX | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.13 | 35.93 |
| Support Level | $0.19 | $1.08 |
| Resistance Level | $0.55 | $1.19 |
| Average True Range (ATR) | 0.04 | 0.06 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 47.57 | 19.97 |
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.